Provides coverage of remotely connected insulin pens under the pharmacy benefit of medical assistance for eligible patients with diabetes.
Summary
Bill S03271 aims to amend the social services law in New York to provide coverage for remotely connected insulin pens for patients with diabetes. These devices are designed to operate interactively or autonomously for individuals aged seven years and older, with provisions for younger patients under adult supervision. The bill mandates that coverage for these insulin pens be included under the pharmacy benefit of medical assistance, ensuring that eligible patients can access this technology as part of their diabetes management.
Impact
If enacted, this bill would expand the scope of medical assistance in New York by including coverage for advanced diabetes management tools, specifically remotely connected insulin pens. This change would potentially improve health outcomes for patients with diabetes by facilitating better insulin delivery and monitoring. The financial implications for managed care organizations would also be significant, as they would need to adjust premium payments to accommodate the costs associated with this new benefit.
Sentiment
The general sentiment surrounding Bill S03271 appears to be positive, as it addresses a critical need for improved diabetes management tools among patients. Discussions in committee have highlighted the importance of accessibility to advanced medical devices, suggesting a supportive stance from health advocates and stakeholders in the diabetes community.
Contention
While the bill has garnered support, there may be points of contention regarding the cost implications for managed care organizations and the overall budget for medical assistance programs. Some stakeholders may express concerns about the sustainability of funding for this new coverage, particularly in the context of existing healthcare expenditures.
Requires Medicaid coverage for continuous glucose monitors and related supplies for individuals diagnosed with diabetes who meet certain coverage eligibility criteria.
Allows remote patient monitoring of pregnant patients; requires reimbursement for remote patient monitoring rendered to certain Medicaid beneficiaries.